LB Pharmaceuticals Inc (LBRX) stock
LBRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$40.06−0.24 (-0.60%)
Close on Nov 18, 2026Market cap $1.29BP/E –Yield –
LB Pharmaceuticals net income
Net income is the profit left for shareholders after every expense, interest and tax.
LB Pharmaceuticals's net income for the twelve months ending Jun 30, 2026 was -$85.69M. For fiscal 2025 it was -$25.21M.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$25.21M | – |
| FY2024 | Dec 31, 2024 | -$63.10M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$51.60M | – |
| Q1 FY2026 | Mar 31, 2026 | -$19.05M | – |
| Q4 FY2025 | Dec 31, 2025 | -$11.47M | – |
| Q3 FY2025 | Sep 30, 2025 | -$3.56M | – |
| Q2 FY2025 | Jun 30, 2025 | -$4.87M | – |
| Q1 FY2025 | Mar 31, 2025 | -$5.31M | – |
| Q4 FY2024 | Dec 31, 2024 | -$5.07M | – |
| Q3 FY2024 | Sep 30, 2024 | -$14.18M | – |
| Q2 FY2024 | Jun 30, 2024 | -$27.63M | – |
| Q1 FY2024 | Mar 31, 2024 | -$16.22M | – |
See a number that looks wrong?